English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/49899
logo share SHARE   Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:


Orally delivered exopolysaccharide-producing Bifidobacterium strains modify the intestinal microbiota dynamic in rats

AuthorsSalazar, Nuria ; Binetti, Ana; Gueimonde Fernández, Miguel ; Alonso, Ana ; Garrido, Pablo; González, Celestino; Ruas-Madiedo, Patricia ; González de los Reyes-Gavilán, Clara
Intestinal microbiota
Issue Date15-Feb-2011
PublisherEuropean Science Foundation
CitationWorkshop of the European Network for Gastrointestinal Health Research (ENGIHR) (1. 2011. Braga, Portugal)
AbstractAccording to the FAO/WHO guidelines, the selecton of probiotics for food applications must follow rational criteria that involve the use of both in vitro and in vivo studies. Previously, we have demonstrated that exopolysaccharides (EPS) purified from intestinal bifidobacteria and lactobacilli are able to act as fermentable substrates by the human intestinal microbiota.
Description1 página.
Appears in Collections:(IPLA) Comunicaciones congresos
Files in This Item:
File Description SizeFormat 
Exopolysaccharide.pdf7,69 kBAdobe PDFThumbnail
Show full item record
Review this work

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.